GLP-1/glucagon co-agonism lowers liver fat more than GLP-1 but not glucagon mono-agonism in obese mice

被引：0
|
作者：
Winther-Sorensen, M. [1 ,2 ]
Rasmussen, C. [1 ]
Trammell, S. A. J. [3 ]
Serizawa, R. R. [4 ]
Vyberg, M. [4 ]
Richter, E. A. [5 ]
Grevengoed, T. [3 ]
Gluud, L. L. [6 ]
Kuhre, R. E. [7 ,8 ]
Albrechtsen, N. J. Wewer [1 ,2 ]
机构：
[1] Bispebjerg Hosp, Dept Clin Biochem, Copenhagen NV, Denmark
[2] Univ Copenhagen, NNF Ctr Prot Res, Copenhagen N, Denmark
[3] Univ Copenhagen, Dept Biomed Sci, Copenhagen N, Denmark
[4] Copenhagen Univ Hosp Hvidovre, Dept Pathol, Hvidovre, Denmark
[5] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark
[6] Copenhagen Univ Hosp Hvidovre, Gastro Unit, Hvidovre, Denmark
[7] Novo Nordisk, Dept Obes, Malov, Denmark
[8] Novo Nordisk, NASH Pharmacol, Malov, Denmark
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LBA 57
引用
收藏
页码：S536 / S536
页数：1
相关论文
共 50 条
  • [31] Biased agonism alters GLP-1 receptor trafficking and glucose homeostasis
    Jones, B.
    Buenaventura, T.
    Owen, B.
    Correa, I. R., Jr.
    Johnson, P.
    Bosco, D.
    Bloom, S. R.
    Rutter, G. A.
    Tomas, A.
    DIABETOLOGIA, 2016, 59 : S72 - S73
  • [32] Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling
    Scrocchi, LA
    Marshall, BA
    Cook, SM
    Brubaker, PL
    Drucker, DJ
    DIABETES, 1998, 47 (04) : 632 - 639
  • [33] Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9-36 Amide at the GLP-1 Receptor
    Li, Naichang
    Lu, Jing
    Willars, Gary B.
    PLOS ONE, 2012, 7 (10):
  • [34] Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight
    Maria S. Svane
    Helle H. Johannesen
    Adam E. Hansen
    Christoffer Martinussen
    Kirstine N. Bojsen-Møller
    Martin Lundsgaard Hansen
    Carolyn F. Deacon
    Sune H. Keller
    Thomas L. Klausen
    Annika Loft
    Andreas Kjaer
    Johan Löfgren
    Sten Madsbad
    Jens J. Holst
    Nicolai J. Wewer Albrechtsen
    International Journal of Obesity, 2022, 46 : 2058 - 2062
  • [35] Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight
    Svane, Maria S.
    Johannesen, Helle H.
    Hansen, Adam E.
    Martinussen, Christoffer
    Bojsen-Moller, Kirstine N.
    Hansen, Martin Lundsgaard
    Deacon, Carolyn F.
    Keller, Sune H.
    Klausen, Thomas L.
    Loft, Annika
    Kjaer, Andreas
    Lofgren, Johan
    Madsbad, Sten
    Holst, Jens J.
    Albrechtsen, Nicolai J. Wewer
    INTERNATIONAL JOURNAL OF OBESITY, 2022, 46 (11) : 2058 - 2062
  • [36] The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism
    Wootten, Denise
    Reynolds, Christopher A.
    Smith, Kevin J.
    Mobarec, Juan C.
    Koole, Cassandra
    Savage, Emilia E.
    Pabreja, Kavita
    Simms, John
    Sridhar, Rohan
    Furness, Sebastian G. B.
    Liu, Mengjie
    Thompson, Philip E.
    Miller, Laurence J.
    Christopoulos, Arthur
    Sexton, Patrick M.
    CELL, 2016, 165 (07) : 1632 - 1643
  • [37] Glucagon Stimulates Insulin Secretion through Both Glucagon and GLP-1 Receptors
    Encisco, Sara
    Svendsen, Berit
    D'Alessio, David A.
    Campbell, Jonathan
    DIABETES, 2017, 66 : A584 - A584
  • [38] Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice
    Kissow, Hannelouise
    Hartmann, Bolette
    Holst, Jens Juul
    Viby, Niels-Erik
    Hansen, Laerke Schmidt
    Rosenkilde, Mette Marie
    Hare, Kristine Juul
    Poulsen, Steen Seier
    REGULATORY PEPTIDES, 2012, 179 (1-3) : 91 - 100
  • [39] GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
    Nikhil R. Gandasi
    Rui Gao
    Lakshmi Kothegala
    Abigail Pearce
    Cristiano Santos
    Samuel Acreman
    Davide Basco
    Anna Benrick
    Margarita V. Chibalina
    Anne Clark
    Claudia Guida
    Matthew Harris
    Paul R. V. Johnson
    Jakob G. Knudsen
    Jinfang Ma
    Caroline Miranda
    Makoto Shigeto
    Andrei I. Tarasov
    Ho Yan Yeung
    Bernard Thorens
    Ingrid W. Asterholm
    Quan Zhang
    Reshma Ramracheya
    Graham Ladds
    Patrik Rorsman
    Diabetologia, 2024, 67 : 528 - 546
  • [40] Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition
    Patel, Vishal
    Joharapurkar, Amit
    Kshirsagar, Samadhan
    Sutariya, Brijesh
    Patel, Maulik
    Pandey, Dheerendra
    Patel, Hiren
    Ranvir, Ramchandra
    Kadam, Shekhar
    Patel, Dipam
    Bahekar, Rajesh
    Jain, Mukul
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 282 : 13 - 21
12345